View in EDS

2317P Assessing the cost-effective price-range for pembrolizumab in treating PD-L1–high advanced non-small cell lung cancer (NSCLC) in South Africa.

Saved in:
Bibliographic Details
Title: 2317P Assessing the cost-effective price-range for pembrolizumab in treating PD-L1–high advanced non-small cell lung cancer (NSCLC) in South Africa.
Authors: Trapani, D.1 (AUTHOR), Ruff, P.2 (AUTHOR), Cairoli, F.3 (AUTHOR), Burrone, E.4 (AUTHOR), Segafredo, G.4 (AUTHOR)
Source: Annals of Oncology. 2025 Supplement 2, Vol. 36, pS1272-S1272. 1p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 189420703
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: 2317P Assessing the cost-effective price-range for pembrolizumab in treating PD-L1–high advanced non-small cell lung cancer (NSCLC) in South Africa.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Trapani%2C+D%2E%22">Trapani, D.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ruff%2C+P%2E%22">Ruff, P.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cairoli%2C+F%2E%22">Cairoli, F.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Burrone%2C+E%2E%22">Burrone, E.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Segafredo%2C+G%2E%22">Segafredo, G.</searchLink><relatesTo>4</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2025 Supplement 2, Vol. 36, pS1272-S1272. 1p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=189420703
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.annonc.2025.08.2933
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 1
        StartPage: S1272
    Titles:
      – TitleFull: 2317P Assessing the cost-effective price-range for pembrolizumab in treating PD-L1–high advanced non-small cell lung cancer (NSCLC) in South Africa.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Trapani, D.
      – PersonEntity:
          Name:
            NameFull: Ruff, P.
      – PersonEntity:
          Name:
            NameFull: Cairoli, F.
      – PersonEntity:
          Name:
            NameFull: Burrone, E.
      – PersonEntity:
          Name:
            NameFull: Segafredo, G.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 09
              Text: 2025 Supplement 2
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 09237534
          Numbering:
            – Type: volume
              Value: 36
          Titles:
            – TitleFull: Annals of Oncology
              Type: main
ResultId 1